The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.00
Ask: 10.00
Change: 0.25 (2.70%)
Spread: 1.00 (11.111%)
Open: 9.50
High: 9.50
Low: 9.50
Prev. Close: 9.25
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Competitive Advantage and Comparison Presentation

7 Oct 2021 07:00

RNS Number : 3334O
Aura Energy Limited
07 October 2021
 

 

AURA ENERGY LIMITED

 ("Aura" or the "Company")

7 October 2021

New Competitive Advantage and Comparison Presentation

Aura is pleased to announce that a new Competitive Advantage and Comparison presentation is available at:

http://www.rns-pdf.londonstockexchange.com/rns/3334O_1-2021-10-7.pdf

For Further Information, please contact:

 

Martin Rogers

Aura Energy Limited

Non-Executive Chairman

martin@ktmcapital.com.au

+61 428 268 357

Jane Morgan

JMM

Investor & Media Relations

jm@janemorganmanagement.com.au

+61 405 555 618

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

Ewan Leggat

Caroline Rowe

Telephone: +44 (0) 203 470 0470

 

WH Ireland Limited(Joint Broker)

Adrian Hadden

Andrew de Andrade

Telephone: +44 (0) 207 220 1666

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGBAUUPGUAM
Date   Source Headline
21st Sep 20229:32 amRNSHolding(s) in Company
19th Sep 20227:21 amRNSDavid Woodall Appointed as MD & CEO
12th Sep 20228:42 amRNSIssue of Equity
9th Sep 20228:22 amRNSHolding(s) in Company
6th Sep 20227:00 amRNSSUBMISSION OF EXPORT PRIOR AUTHORISATION
30th Aug 202211:51 amRNSHolding(s) in Company
25th Aug 20227:55 amRNSHolding(s) in Company
1st Aug 20228:12 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSTotal Voting Rights
29th Jul 20227:42 amRNSQuarterly Report for Period Ending 30 June 2022
20th Jul 20228:46 amRNSIssue of Equity
19th Jul 202211:10 amRNSIssue of Equity
1st Jul 20229:40 amRNSLoan Funded Shares and Total Voting Rights
30th Jun 20227:00 amRNSCAPEX AND OPEX ENGINEERING OPTIMISATION COMMENCED
29th Jun 202211:07 amRNSHolding(s) in Company
27th Jun 20227:00 amRNSHolding(s) in Company
23rd Jun 20227:00 amRNSPilot Tests at Tiris Uranium Project
27th May 20227:00 amRNSDrilling for the Tiris Uranium Resource Upgrade
23rd May 20227:00 amRNSIssue of Equity
18th May 20227:00 amRNSUranium Specialist Patrick Mutz Joins Aura Board
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSNew Corporate Presentation
3rd May 20227:40 amRNSIssue of Equity
27th Apr 20227:42 amRNSQuarterly Report for the Period Ending 31 March 22
21st Apr 20227:52 amRNSIssue of Equity
19th Apr 20227:00 amRNSUranium Resource Upgrade Programme Underway
6th Apr 202210:12 amRNSIssue of Equity
1st Apr 20227:00 amRNSIssue of Loan Funded Shares
25th Mar 20227:00 amRNSSupplement to 31 December 2021 Half Year Report
23rd Mar 20229:56 amRNSIssue of Equity
17th Mar 20227:41 amRNSIssue of Equity
17th Mar 20227:30 amRNSCleansing Prospectus
14th Mar 20227:00 amRNSFirm commitments for A$8.8 million placement
9th Mar 20227:52 amRNSASX Trading Halt
8th Mar 20228:12 amRNSHalf-year Report
8th Mar 20227:55 amRNSInvestor Webinar
4th Mar 20229:18 amRNSIssue of Equity
1st Mar 202210:17 amRNSMedia Release
17th Feb 20228:56 amRNSIssue of Equity
16th Feb 20227:00 amRNSInvestor Presentation
16th Feb 20227:00 amRNSAura Defines Vanadium JORC Resource
14th Feb 20227:00 amRNSGlobal X Uranium ETF Add Aura Energy
9th Feb 20227:00 amRNSTiris Uranium Resource Enhancement Programme
1st Feb 20229:36 amRNSIssue of Equity
28th Jan 20227:04 amRNSQuarterly Report
27th Jan 20227:00 amRNSNet Zero Emission Study
20th Jan 20227:00 amRNSChairman’s Letter
18th Jan 20229:40 amRNSIssue of Equity
13th Jan 20228:06 amRNSDr Will Goodall Appointed as Acting CEO of Aura

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.